Stephen Bardin's most recent trade in CalciMedica Inc was a trade of 130,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 23, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
CalciMedica Inc | Stephen Bardin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2025 | 130,000 | 130,000 | - | - | Employee Stock Option (Right to Buy) | |
ATAI Life Sciences N.V. | Stephen Bardin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 600,000 | 600,000 | - | - | Stock Option | |
ATAI Life Sciences N.V. | Stephen Bardin | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 350,000 | 350,000 | - | - | Restricted Stock Unit |